Clinical Trial Update: Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether udenafil can reduce liver stiffness in Fontan-associated liver disease in patients with single-ventricle heart disease. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Single-ventricle Heart Disease

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Mezzion Pharma Co. Ltd | Conditions: Single Ventricle Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-09-18